NCT07287098
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07287098
Title A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer (PreEMBER)
Acronym PreEMBER
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | DEU | BEL

Facility Status City State Zip Country Details
Oncology Consultants P.A. Houston Texas 77030 United States Details
Cliniques universitaires Saint-Luc Brussels 1200 Belgium Details
Antwerp University Hospital Edegem 2650 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
CHRU de Brest Brest 29609 France Details
Centre de Cancérologie du Grand Montpellier Montpellier 34070 France Details
Universitaetsklinikum Erlangen Erlangen 91054 Germany Details
Ente Ospedaliero Ospedali Galliera Genova 16128 Italy Details
Humanitas Milan 20089 Italy Details
Humanitas Istituto Clinico Catanese Misterbianco 95045 Italy Details
Nuovo Ospedale di Prato-S.Stefano Prato 59100 Italy Details
Fondazione Policlinico Universitario Agostino Gemelli Roma 00168 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field